Search research articles
Contact Us
Filters
Showing results (181-190 of 319) with videos related to
Page
of 32
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2011
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging
Alexander B Stillebroer, Catharina M L Zegers, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2015
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3
Samantha Y A Terry, Marije I Koenders, Gerben M Franssen, et al.
EJNMMI Research
|
June 28, 2015
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
Mark W Konijnenberg, Wout A P Breeman, Erik de Blois, et al.
Theranostics
|
June 28, 2019
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors
Susanne Lütje, Sandra Heskamp, Gerben M Franssen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 16, 2006
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides
Ingrid Dijkgraaf, John A W Kruijtzer, Shuang Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 8, 2003
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice
Iris Verel, Gerard W M Visser, Ronald Boellaard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2005
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting
Frank G van Schaijk, Matthias Broekema, Egbert Oosterwijk, et al.
Cardiovascular Diabetology
|
October 12, 2012
Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study
Richard Engbersen, Niels P Riksen, Marc J Mol, et al.
Cancer Research
|
November 5, 2002
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model
Marcel L Janssen, Wim J Oyen, Ingrid Dijkgraaf, et al.
Chembiochem : a European Journal of Chemical Biology
|
February 18, 2011
Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method
Cheng-Bin Yim, Berend van der Wildt, Ingrid Dijkgraaf, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 319) with videos related to
Sort By:
Page
of 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2011
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging
Alexander B Stillebroer, Catharina M L Zegers, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2015
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3
Samantha Y A Terry, Marije I Koenders, Gerben M Franssen, et al.
EJNMMI Research
|
June 28, 2015
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
Mark W Konijnenberg, Wout A P Breeman, Erik de Blois, et al.
Theranostics
|
June 28, 2019
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors
Susanne Lütje, Sandra Heskamp, Gerben M Franssen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 16, 2006
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides
Ingrid Dijkgraaf, John A W Kruijtzer, Shuang Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 8, 2003
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice
Iris Verel, Gerard W M Visser, Ronald Boellaard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 7, 2005
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting
Frank G van Schaijk, Matthias Broekema, Egbert Oosterwijk, et al.
Cardiovascular Diabetology
|
October 12, 2012
Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study
Richard Engbersen, Niels P Riksen, Marc J Mol, et al.
Cancer Research
|
November 5, 2002
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model
Marcel L Janssen, Wim J Oyen, Ingrid Dijkgraaf, et al.
Chembiochem : a European Journal of Chemical Biology
|
February 18, 2011
Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method
Cheng-Bin Yim, Berend van der Wildt, Ingrid Dijkgraaf, et al.
Page
of 32